SCHEMBL23648337

SCHEMBL23648337

Cc1ccc(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)cc1N

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CASP1 P29466 1/20 0.33
PARP1 P09874 1/20 0.32
IDO1 P14902 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30
NFKB1 P19838 1/20 0.30
RAB9A P51151 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ALOX5AP P20292 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26015840 0.90 SKP2 (0.40) CYP3A4TDP1TSHRALDH1A1IDO1
SCHEMBL29649528 0.90 SKP2 (0.40) CYP3A4TDP1TSHRALDH1A1IDO1
SCHEMBL31190921 0.85 ALDH1A1 (0.40) CYP3A4TDP1ALDH1A1KDM4EMAPT
SCHEMBL26015871 0.82 ALDH1A1 (0.50) CYP3A4TDP1TSHRALDH1A1
SCHEMBL29649556 0.82 ALDH1A1 (0.50) CYP3A4TDP1TSHRALDH1A1
SCHEMBL222047 0.81 MAOB (0.43) IDO1MAPTRAB9ASMN1; SMN2
SCHEMBL6622204 0.80 MAOB (0.47) IDO1MAPT
SCHEMBL8292247 0.80 MAPT (0.41) CYP3A4TDP1TSHRALDH1A1IDO1
SCHEMBL14542685 0.79 AGXT (0.43) CYP3A4TDP1ALDH1A1IDO1KDM4E
SCHEMBL6648058 0.79 SMYD2 (0.32) CYP3A4TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070913-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME KOREA INST SCI & TECH (KR) 2026-03-12 US disclosed
US-20230103742-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-04-06 US disclosed
EP-4092029-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME Korea Institute of Science and Technology (KR) 2022-11-23 EP disclosed
WO-2021145520-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 한국과학기술연구원 2021-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103742-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME HASPIN, WEE2, CDK7 CYP3A4 4072/4885TDP1 2214/4885TSHR 4836/4885
US-20260070913-A1 7-AMINO-3,4-DIHYDROPYRIMIDOPYRIMIDIN-2-ONE DERIVATIVE HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME CSNK1A1, CKS1B, HGFAC CYP3A4 4568/4885TDP1 3403/4885TSHR 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.